| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Affiliated Person
2 companies
Forsyth Douglas serves as a Director at INBX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 3 buys and 9 sells. Those positions are worth an estimated $26.1M at current prices.
The biggest single holding is INBX (~$26.0M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 77,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 2,500 | $114.65 | $286,617.25 | +1.1% | - | - | |
| Aug 23, 2024 | INBX Inhibrx Biosciences, Inc. | Director | Buy | 75,000 | $13.83 | $1,037,328.16 | +50.1% | +4.8% | +87.4% | |
| Aug 11, 2020 | NIE Virtus Equity & Convertible Income Fund | Affiliated Person | Sell | 20,000 | $24.66 | $493,270.73 | -100% | - | - |